Pradžia › Plaučių hipertenzija › Virginia
Plaučių hipertenzija klinikiniai tyrimai Virginia
6 tyrimai dėl Plaučių hipertenzija ieško dalyvių vietose Virginia.
Miestai Virginia
Oficialus tyrimo tekstas (anglų kalba)
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA008, Richmond
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Virginia Commonwealth University, Richmond
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Inova Medical Group, Falls Church
- Sentara Norfolk General Hospital, Norfolk
- Pulmonary Associates of Richmond, Inc., Richmond
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT06388421Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- Sentara Norfolk General Hospital, Norfolk
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-18 · NCT07087613Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Virginia Medical Center, Charlottesville
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-10 · NCT06526195Pulmonary Hypertension Association Registry
- University of Virginia, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Sentara Heart Hospital, Norfolk
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Amžius 0 ir vyresni · Visoms lytims · Atnaujinta 2025-11-14 · NCT04071327Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.